Past infections have long-term effects on liver immune cells 

Many infections affect the liver, yet little is known about the long-term impact of these infections on the liver’s immune cells. Now, a study by the teams of Prof. Jo Van Ginderachter (VIB-VUB) and Prof Kiavash Movahedi at VUB reveals long-lasting changes in the liver’s Kupffer cells following an infection. The work appears in the Journal of Hepatology

The role of Kupffer cells 

Our immune system is a complex network of cells and molecules that work together to protect our bodies from harmful invaders like bacteria, viruses, and parasites. Among the key players in this defense system are macrophages, specialized immune cells that act as the first line of defense against infections. In the liver, a vital organ responsible for filtering, a specific type of macrophage called Kupffer cells plays a crucial role in monitoring the blood for pathogens. 

Yet, the long-term effects of infections on the liver immune cells, including Kupffer cells, are unknown. Researchers from the lab of Prof. Jo Van Ginderachter at the VIB Center for Inflammation Research and Prof Kiavash Movahedi at VUB, with colleagues from UGent and the VIB Single Cell Core studied the lingering effects of infection with the parasite Trypanosoma brucei brucei on the liver immune cells (in a mouse model for human sleeping sickness). 

The research team, with Prof. Jo Van Ginderachter in the center.

A lasting mark 

By using cutting-edge techniques such as fate mapping, single-cell sequencing, and epigenetic analysis, the researchers – led by PhD student Mohamed Amer Musrati and Dr. Benoit Stijlemans – acquired a detailed look at the changes in the liver following infection. 

They found that Trypanosoma infections strongly alter the composition of macrophages in the liver, identifying several newly recruited populations that altered their gene expression to fight the infection. Remarkably, after the infection is cleared, the Kupffer Cells bear long-lasting changes in the accessibility and expression of certain genes, highlighting the enduring impact of past infections on our immune system. 

Importantly, the mice who had gone through an earlier infection were more resilient to a subsequent infection with another pathogen, which suggests that an infection reprograms the liver’s Kupffer cells to better fight future infections. In other words, our infection history may influence the way we can deal with future infections due to macrophage reprogramming. ​ 

Prof. Jo Van Ginderachter says, “By unraveling the long-term effects of infections on liver macrophages, this study opens up new avenues for understanding and treating infectious diseases.” 

Funding 

This work was supported by FWO, ERC, an iBOF research consortium, and the European Regional Development Fund (ERDF). 

Publication 

Infection history imprints prolonged changes to the epigenome, transcriptome, and function of Kupffer Cells. Musrati, Stijlemans, et al. Journal of Hepatology, 2024. 


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

 

 

Share

Latest stories

Website preview
Researchers identify a key biological tipping point in Alzheimer’s disease
Leuven, 4 June 2026 – Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether Alzheimer’s disease pathology leads to dementia. Studying brain tissue from older adults with and without cognitive decline, as well as cognitively healthy centenarians, the team identified distinct cellular programs and immune-cell states associated with disease progression and resilience. Their findings, published in Nature Medicine, suggest that changes in microglia—the brain’s resident immune cells—could represent an important target for future Alzheimer’s therapies.
press.vib.be
Website preview
Prof. Diether Lambrechts (KU Leuven/VIB) receives the Francqui-Collen Prize 2026
Brussels, June 2, 2026 – Prof. Dr. Diether Lambrechts (KU Leuven/VIB) and Prof. Dr. Patrice Cani (UCLouvain) are the laureates of the Francqui-Collen Prize 2026, one of the highest scientific distinctions in Belgium. Today, they receive the award from the hands of King Philippe. Prof. Lambrechts is being honored for his groundbreaking genetic research into cancer treatments, while Prof. Cani is recognized for his discoveries regarding the impact of gut bacteria on lifestyle-related diseases.
press.vib.be
Website preview
Comprehensive atlas maps dendritic cells across cancers
Brussels, 01 June 2026 — Researchers from VIB, VUB, and an international network of collaborators have created the most comprehensive single-cell atlas to date of tumor-associated dendritic cells. By integrating data from 14 mouse tumor models and 10 human cancer types, the study provides a detailed, cross-species view of how these key immune cells are organized and altered in cancer. This work, which appeared in Nature Communications, can guide the development of next-generation therapies.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be